---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "zjNJxDxz1nIQtiQcVEAh+B067WcOpfK/sDtWZ5iFC0YLz1L2NGue2eTW9TeDfSnrQRx5qZtYQ+oWIoP12xfSamkUytr8Gc9fN/raLUuMhDgHj8lHeMZCgytnkzgMMO/AfuzkYCfB9/mUZ/GzYw/lGPIN6mG91QSYwmI+FXNwJqds9dUZYNpOkqFZP2FaDqtq0mCV187t8uh90QrLbYxiNV82qqL4qzVZXUh59iyvo8Fk5YXegfLFReRmMpoUtlPsXEPejKDS/v/xXmF/xMiDn5EAwMSwMrdtAEaUd5h+Lrr4YxH7lZRwij0BMXR4EVOMf4VwC/fK8JZVPn3A8E8z/uEcmhZNNhjb65dTb2tXXrg=;IMle98yOKrei475rRpTrhw=="
---

